Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Depreciation & Amortization - Total (2022 - 2025)

Core Laboratories' Depreciation & Amortization - Total history spans 4 years, with the latest figure at $3.6 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization - Total rose 1.89% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $14.3 million, down 1.1%, while the annual FY2025 figure was $14.3 million, 1.1% down from the prior year.
  • Depreciation & Amortization - Total reached $3.6 million in Q4 2025 per CLB's latest filing, up from $3.5 million in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $4.2 million in Q2 2022 to a low of $3.5 million in Q3 2025.
  • Average Depreciation & Amortization - Total over 4 years is $3.7 million, with a median of $3.7 million recorded in 2024.
  • Peak YoY movement for Depreciation & Amortization - Total: decreased 9.12% in 2023, then increased 1.89% in 2025.
  • A 4-year view of Depreciation & Amortization - Total shows it stood at $3.9 million in 2022, then decreased by 4.05% to $3.7 million in 2023, then dropped by 5.5% to $3.5 million in 2024, then increased by 1.89% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Depreciation & Amortization - Total are $3.6 million (Q4 2025), $3.5 million (Q3 2025), and $3.6 million (Q2 2025).